Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 2, 2009, Pages 249-253

  Zhang, Hailiang ^a   Ye, Dingwei ^a   Yao, Xudong ^a   Dai, Bo ^a   Zhang, Shilin ^a   Shen, Yijun ^a   Zhu, Yao ^a   Mao, Huirong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Immunohistochemistry; KIT; Renal cell carcinoma; Survival

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ARTICLE; ASIAN; CANCER STAGING; CHINA; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 63149189502     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-008-0447-6     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 57:43-66
2. Shiina HIM, Urakami S (2004) Clinical signiWcance of prognostic Factors in patients with advanced renal cell carcinoma: development of an International Kidney Cancer Working Group. Clin Cancer Res (suppl) 15:6310-6314
3. Gibson PC, Cooper K (2002) CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 9:65-69
4. Greene FL PD, Fleming ID (2002) AJCC Cancer Staging Manual, 6th edn, Springer, Heidelberg
5. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic signiWcance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663. doi:10.1097/00000478-198210000-00007
6. D'Amato G, Steinert DM, McAuliVe JC et al (2005) Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control 12:44-56
7. Goss GAMP, Manola J (2000) Clinical and pathological characteristics of gastrointestinal stromal tumors. Prog Pros Am Soc Clin Oncol 19:599a
8. Hornick JL, Fletcher CD (2004) The significance of KIT (CD117) in gastrointestinal stromal tumors. Int J Surg Pathol 12:93-97
9. Yamazaki K, Sakamoto M, Ohta T et al (2003) Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 22:847-852. doi:10.1038/sj.onc. 1206153
10. Miliaras D, Karasavvidou F, Papanikolaou A et al (2004) KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 57:463-466. doi:10.1136/jcp.2003.013532
11. Zigeuner RRM, Langner C (2005) Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas. BJU Int 95:315-318. doi:10.1111/j.1464-410X.2005.05290.X
12. Pan CC, Chen PC (2004) A distinct expression pattern and point mutation of c-KIT in papillary renal cell carcinomas. Mod Pathol 17:1440-1441
13. Hornick JL, Fletcher CD (2003) Validating immunohistochemical staining for KIT (CD117). Am J Clin Pathol 119:325-327. doi:10.1309/EJ3R-Y45Q-CYPU-KQG4
14. Phuoc NB, Ehara H, Gotoh T et al (2007) Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Urology 69:843-848. doi:10.1016/j.urology.2007.01.069
15. Ljungberg B, Bozoky B, Kovacs G et al (2001) p53 expression in correlation to clinical outcome in patients with renal cell carcinoma. Scand J Urol Nephrol 35:15-20. doi:10.1080/00365590151030705
16. Zigeuner R, Ratschek M, Rehak P et al (2004) Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Urology 63:651-655. doi:10.1016/j.urology. 2003.11.011
17. Lee JM (1998) Inhibition of p53-dependent apoptosis by the KIT tyrosine kinase: regulation of mitochondrial permeability transition and reactive oxygen species generation. Oncogene 17:1653-1662. doi:10.1038/sj.onc.1202102